Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 10:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 183 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Women Contraception Clear all

Conditions: Gestational Diabetes, Glucose Intolerance, Type 2 Diabetes, Intrauterine Contraception
Interventions: Mirena (Levonorgestrel IUD), Paragard (Copper IUD ) or Tubal Ligation; Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Epilepsy, Contraception
Interventions: levonorgestrel IUS; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Ligament Injury
Interventions: Oral Contraceptive Pill, norethindrn a-e estradiol-iron; Drug
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 73 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Contraception
Interventions: Levonorgestrel Intrauterine System (LNG-IUS: Mirena, Bayer); Device
Lead sponsor: United States Naval Medical Center, Portsmouth; Federal
Eligibility: 16 Years to 45 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Portsmouth, Virginia

Conditions: Cervical Cancer, Breast Cancer, Contraceptive Usage, Sexually Transmitted Diseases
Interventions: SHE-WOMEN; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 279 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: CKD, Chronic Kidney Diseases
Interventions: Decision aid, Standard handout; Behavioral · Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Hormonal Contraception
Interventions: Depot medroxyprogesterone acetate (DMPA), Etonogestrel implant (Eng-Implant), Levonorgestrel IUD (Lng-IUD); Drug
Lead sponsor: Emory University; Other
Eligibility: Up to 45 Years · Female only
Enrollment: 155 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 3
States / cities: Atlanta, Georgia

Conditions: Preterm Birth, Health Care Utilization, Tobacco Use, Contraceptive Usage, Depression, Weight, Birth
Interventions: Care coordination and motivational interviewing; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 14 Years to 45 Years · Female only
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cystic Fibrosis, Contraception, Physician-Patient Relations, Pregnancy Complications
Interventions: MyVoice:CF; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Weight Gain, Women's Health, Obesity
Interventions: Weight-gain Prevention, Women's Health; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Contraception
Interventions: group family planning counseling, Individual family planning counseling; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 648 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Contraception, Postpartum Depression, Lactation
Interventions: Depot medroxyprogesterone acetate; Drug
Lead sponsor: Beatrice Chen; Other
Eligibility: 18 Years and older · Female only
Enrollment: 184 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Contraceptive Usage, Opioid Dependence
Interventions: Contraceptive management program, Usual care; Behavioral · Other
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Weight Gain, Disorder of Bone Density and Structure, Unspecified, Uterine Bleeding
Interventions: Depot medroxyprogesterone acetate (DMPA); Drug
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 12 Years to 21 Years · Female only
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Ovarian Suppression
Interventions: Low dose formulation, High dose formulation; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 226 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Contraception
Interventions: NES/EE CVR; Combination Product
Lead sponsor: Population Council; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 1,135 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2014
U.S. locations: 5
States / cities: Los Angeles, California • San Francisco, California • Chicago, Illinois + 2 more

Conditions: Emergency Contraception
Interventions: Copper IUD, Levonorgestrel IUD; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Contraception, Ovulation Inhibition, Contraceptives, Oral
Interventions: EE20/DRSP (BAY86-5300), EE20/DRSP (YAZ, BAY86-5300); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 1,887 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 85
States / cities: Montgomery, Alabama • Chandler, Arizona • Mesa, Arizona + 74 more

Conditions: Contraception
Interventions: MR-100A-01; Drug
Lead sponsor: Mylan Technologies Inc.; Industry
Eligibility: 16 Years and older · Female only
Enrollment: 1,320 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 96
States / cities: Mobile, Alabama • Mesa, Arizona • Phoenix, Arizona + 72 more

Conditions: Contraception, Obesity
Interventions: Not listed
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Female Contraception
Interventions: Transdermal system containing progestin; Drug
Lead sponsor: Mylan Pharmaceuticals Inc; Industry
Eligibility: 16 Years and older · Female only
Enrollment: 1,630 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 56
States / cities: Birmingham, Alabama • Dothan, Alabama • Mobile, Alabama + 40 more

Conditions: Delay in Time to Lactogenesis Stage II
Interventions: Depo-Provera Injectable Product, Placebos; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Polycystic Ovary Syndrome
Interventions: Etonogestrel/ethinyl estradiol vaginal ring; Drug
Lead sponsor: Andrea Roe, MD, MPH; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Contraception
Interventions: Blood draw, ESSURE (BAY1454032), Laparoscopic tubal sterilization; Procedure · Device
Lead sponsor: Bayer; Industry
Eligibility: 21 Years and older · Female only
Enrollment: 990 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2024
U.S. locations: 57
States / cities: Chandler, Arizona • Phoenix, Arizona • Tucson, Arizona + 47 more

Search by objective public record fields.

Postpartum Glucose Tolerance With Levonorgesterel IUD Use in Women With Recent Gestational Diabetes

Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users

Do Oral Contraceptives Protect Against ACL Injuries in Female Athletes

Levonorgestrel-Intrauterine System (LNG-IUS) Insertion in the Postpartum Period

Sexual Health Empowerment for Women's Health

Pregnancy and Contraception Education in Chronic Kidney Disease (PACE-CKD)

Contraceptive Hormones, Immunity, and Microbiome Evaluation

Testing Feasibility of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth

MyVoice:CF Decision Aid for Women With Cystic Fibrosis

Preventing Weight Gain in African American Reproductive-Aged Women

A Trial of Group Versus Individual Family Planning Counseling in Ghana

Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression

Improving Effective Contraceptive Use Among Opioid-maintained Women

Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects

Obesity, Oral Contraception, and Ovarian Suppression

Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol

Study of the Copper IUD or Oral Levonorgestrel and the Levonorgestrel IUD for Women Seeking Emergency Contraception

Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ

Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Pharmacokinetics of Implanon in Obese Women

Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential

Postpartum Family Planning

Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS

Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization